Methocarbamol
Methocarbamol Injection, USP RX only
Approved
Approval ID
68dd9c24-4d41-48be-9f54-fceb787bb443
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 18, 2023
Manufacturers
FDA
Somerset Therapeutics, LLC
DUNS: 079947873
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Methocarbamol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70069-101
Application NumberANDA207522
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methocarbamol
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 18, 2023
FDA Product Classification
INGREDIENTS (5)
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
METHOCARBAMOLActive
Quantity: 100 mg in 1 mL
Code: 125OD7737X
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
POLYETHYLENE GLYCOL 300Inactive
Quantity: 0.5 mL in 1 mL
Code: 5655G9Y8AQ
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT